Finally, for CNSs to provide novel targets and strategies, it is necessary to explore the mechanisms whereby CNSs could be manipulated to produce sufficient and stable effector CD4+ T cells relevant to the treatment of immune diseases and cancer. The gene discussed is CD4; the disease is immune system disorder.